echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Lancet sub-issue: Can you eat and drink with normal weight?

    Lancet sub-issue: Can you eat and drink with normal weight?

    • Last Update: 2022-04-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    For many cardiovascular risk factors, there is no further reduction at the lower end of the reduction in disease risk; this includes values ​​considered to be within the normal range for healthy adults
    .


    In other words, improving some bad habits can always benefit our body


    Blood vessels That is to say, improving some bad habits can always benefit our body


    The Comprehensive Evaluation of the Long-Term Effects of Reducing Energy Intake (CALERIE™) was a 24-month multicenter randomized controlled trial (May 2007-November 2012) in healthy adults without obesity to assess The potential of caloric restriction (CR) to promote antiaging adaptations, including those associated with disease risk
    .


    218 participants (age 37.


    The results showed that at 12 and 24 months, the CR group had an average 11.
    9% reduction in caloric intake, not only in body weight (8.
    4 kg; 7.
    5 kg), fat mass (6.
    1 kg; 5.
    3 kg), and fat-free body mass ( 2.
    20 kg; 2.
    17 kg), and cardiovascular disease risk markers, lipoprotein B, and GlycA, the inflammatory marker, and insulin resistance and type 2 diabetes risk--lipoprotein insulin resistance index and diabetes risk index (all PCRvsAL≤0.
    0009) decreased
    .

    Not only were there decreases in able body weight (8.
    4 kg; 7.
    5 kg), fat mass (6.
    1 kg; 5.
    3 kg), and fat-free body mass (2.
    20 kg; 2.
    17 kg), but cardiovascular disease risk markers, lipoprotein B, and inflammatory The marker GlycA, as well as insulin resistance and type 2 diabetes risk, the lipoprotein insulin resistance index and diabetes risk index (all PCRvsAL ≤ 0.
    0009) decreased
    .


    Not only were there decreases in able body weight (8.


    Further analysis revealed that the improvements in insulin resistance and diabetes risk stemmed from CR-induced changes in lipoproteins, specifically a reduction in triglyceride-rich lipoprotein particles and low-density lipoprotein particles in favor of larger high-density lipoprotein particles ( more efficient cholesterol transporter), and a reduction in branched-chain amino acids (BCAAs) (all PCRvsAL ≤ 0.
    004)
    .


    These CR responses were more pronounced in overweight participants than normal weight participants, and more pronounced in men than women


    The improvement in insulin resistance and diabetes risk stems from CR-induced changes in lipoproteins, specifically a reduction in triglyceride-rich lipoprotein particles and low-density lipoprotein particles, and a shift towards larger high-density lipoprotein particles (the more potent cholesterol transport vehicles), and a reduction in branched-chain amino acids (BCAAs) (all PCRvsAL≤0.


    In conclusion, 12-month calorie reduction in normal to slightly overweight adults with no apparent risk factors or disease improved newly identified risk of atherosclerotic cardiovascular disease, insulin resistance, and type 2 diabetes marker


    references:

    Calorie restriction improves lipid-related emerging cardiometabolic risk factors in healthy adults without obesity: Distinct influences of BMI and sex from CALERIE™ a multicentre, phase 2, randomised controlled trial.


    Calorie restriction improves lipid-related emerging cardiometabolic risk factors in healthy adults without obesity: Distinct influences of BMI and sex from CALERIE™ a multicentre, phase 2, randomised controlled trial.
    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.